Site Map | Legal Policy | Privacy Policy

 

SEC Documents

  
Filing Description Date Filed Sorted Descending Size  
10-K annual report Mar 3, 2010 1.1 MB  
SC 13G/A amended statement of beneficial ownership Feb 12, 2010 72.9 KB  
SC 13G/A amended statement of beneficial ownership Feb 12, 2010 22.2 KB  
SC 13G/A amended statement of beneficial ownership Feb 11, 2010 31.1 KB  
SC 13D/A amended general statement of beneficial ownership Feb 10, 2010 34.5 KB  
8-K current report Feb 9, 2010 64.0 KB  
8-K current report Feb 8, 2010 23.0 KB  
SC 13G statement of beneficial ownership Jan 29, 2010 25.0 KB  
8-K current report Jan 28, 2010 597.6 KB  
8-K current report Jan 28, 2010 22.5 KB  
8-K current report Jan 8, 2010 33.3 KB  
425 other Jan 8, 2010 33.3 KB  
8-K current report Dec 24, 2009 414.3 KB  
EFFECT effectiveness order Dec 22, 2009 0.0 KB  
424B3 prospectus filed pursuant to rule 424 Dec 22, 2009 2.8 MB  
425 other Dec 21, 2009 34.5 KB  
8-K current report Dec 21, 2009 52.0 KB  
S-4/A registration statement Dec 17, 2009 2.9 MB  
8-K current report Dec 17, 2009 57.2 KB  
425 other Dec 17, 2009 57.3 KB  
Showing 1-20 of 501 Page: 1 2 3 ... 26  Next 20
News

Ligand to Present at the Cowen & Company 30th Annual Healthc.......

Ligand Announces Fourth Quarter and Full Year 2009 Consolida.......

Upcoming Events

Q4 2009 Results at BIO CEO Conference

Cowen & Company 30th Annual Healthcare Conference

Investor Relations|News|Presentations & Events|SEC Documents|
Corporate Governance|Stock Information|Email Alerts
LGND - (NASDAQ)
$1.71   + 0.01